nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—ABCB1—kidney cancer	0.236	1	CbGaD
Enalapril—ABCB1—Temsirolimus—kidney cancer	0.0543	0.134	CbGbCtD
Enalapril—CYP3A4—Everolimus—kidney cancer	0.0482	0.119	CbGbCtD
Enalapril—CYP3A4—Temsirolimus—kidney cancer	0.0325	0.0802	CbGbCtD
Enalapril—ABCB1—Pazopanib—kidney cancer	0.0285	0.0703	CbGbCtD
Enalapril—ABCB1—Dactinomycin—kidney cancer	0.0261	0.0643	CbGbCtD
Enalapril—ABCB1—Gemcitabine—kidney cancer	0.0206	0.0509	CbGbCtD
Enalapril—ABCB1—Erlotinib—kidney cancer	0.0203	0.0502	CbGbCtD
Enalapril—ACE—renal artery—kidney cancer	0.02	0.234	CbGeAlD
Enalapril—ABCB1—Paclitaxel—kidney cancer	0.0186	0.0459	CbGbCtD
Enalapril—CYP3A4—Pazopanib—kidney cancer	0.0171	0.0421	CbGbCtD
Enalapril—ABCB1—Sorafenib—kidney cancer	0.0165	0.0408	CbGbCtD
Enalapril—ABCB1—Vinblastine—kidney cancer	0.0163	0.0403	CbGbCtD
Enalapril—ABCB1—Vincristine—kidney cancer	0.0161	0.0396	CbGbCtD
Enalapril—ABCB1—Sunitinib—kidney cancer	0.0134	0.0331	CbGbCtD
Enalapril—CYP3A4—Erlotinib—kidney cancer	0.0122	0.0301	CbGbCtD
Enalapril—CYP3A4—Paclitaxel—kidney cancer	0.0112	0.0275	CbGbCtD
Enalapril—ABCB1—Doxorubicin—kidney cancer	0.01	0.0248	CbGbCtD
Enalapril—CYP3A4—Sorafenib—kidney cancer	0.00991	0.0245	CbGbCtD
Enalapril—CYP3A4—Vinblastine—kidney cancer	0.00979	0.0241	CbGbCtD
Enalapril—CYP3A4—Vincristine—kidney cancer	0.00962	0.0237	CbGbCtD
Enalapril—CYP3A4—Sunitinib—kidney cancer	0.00803	0.0198	CbGbCtD
Enalapril—SLC22A8—nephron—kidney cancer	0.00703	0.082	CbGeAlD
Enalapril—ACE—nephron—kidney cancer	0.00701	0.0817	CbGeAlD
Enalapril—CYP3A4—Doxorubicin—kidney cancer	0.00601	0.0148	CbGbCtD
Enalapril—SLC22A8—urine—kidney cancer	0.00564	0.0658	CbGeAlD
Enalapril—ACE—urine—kidney cancer	0.00562	0.0656	CbGeAlD
Enalapril—CYP3A4—urine—kidney cancer	0.00279	0.0326	CbGeAlD
Enalapril—SLC22A6—nephron tubule—kidney cancer	0.00253	0.0296	CbGeAlD
Enalapril—SLC22A7—renal system—kidney cancer	0.00239	0.0278	CbGeAlD
Enalapril—SLC22A7—kidney—kidney cancer	0.00231	0.0269	CbGeAlD
Enalapril—SLC22A7—cortex of kidney—kidney cancer	0.00225	0.0262	CbGeAlD
Enalapril—SLC22A6—cortex of kidney—kidney cancer	0.00217	0.0253	CbGeAlD
Enalapril—SLC15A1—nephron tubule—kidney cancer	0.00211	0.0246	CbGeAlD
Enalapril—SLC15A1—renal system—kidney cancer	0.00192	0.0224	CbGeAlD
Enalapril—SLC15A1—kidney—kidney cancer	0.00185	0.0216	CbGeAlD
Enalapril—SLC22A8—nephron tubule—kidney cancer	0.00152	0.0177	CbGeAlD
Enalapril—ACE—nephron tubule—kidney cancer	0.00151	0.0176	CbGeAlD
Enalapril—SLCO1A2—renal system—kidney cancer	0.00144	0.0169	CbGeAlD
Enalapril—SLCO1A2—kidney—kidney cancer	0.0014	0.0163	CbGeAlD
Enalapril—SLC22A8—renal system—kidney cancer	0.00138	0.0161	CbGeAlD
Enalapril—ACE—renal system—kidney cancer	0.00137	0.016	CbGeAlD
Enalapril—SLC22A8—kidney—kidney cancer	0.00133	0.0156	CbGeAlD
Enalapril—ACE—kidney—kidney cancer	0.00133	0.0155	CbGeAlD
Enalapril—SLC22A8—cortex of kidney—kidney cancer	0.0013	0.0152	CbGeAlD
Enalapril—ACE—cortex of kidney—kidney cancer	0.00129	0.0151	CbGeAlD
Enalapril—ACE—gonad—kidney cancer	0.00123	0.0144	CbGeAlD
Enalapril—ACE—cardiac atrium—kidney cancer	0.00123	0.0144	CbGeAlD
Enalapril—Perindopril—BCHE—kidney cancer	0.00088	0.255	CrCbGaD
Enalapril—Ramipril—BCHE—kidney cancer	0.000751	0.218	CrCbGaD
Enalapril—CYP3A4—renal system—kidney cancer	0.000684	0.00798	CbGeAlD
Enalapril—CYP3A4—kidney—kidney cancer	0.000661	0.00771	CbGeAlD
Enalapril—Captopril—ABCB1—kidney cancer	0.000548	0.159	CrCbGaD
Enalapril—ABCB1—nephron tubule—kidney cancer	0.000532	0.00621	CbGeAlD
Enalapril—ABCB1—renal system—kidney cancer	0.000484	0.00565	CbGeAlD
Enalapril—ABCB1—kidney—kidney cancer	0.000468	0.00546	CbGeAlD
Enalapril—ABCB1—cortex of kidney—kidney cancer	0.000456	0.00532	CbGeAlD
Enalapril—ABCB1—gonad—kidney cancer	0.000434	0.00506	CbGeAlD
Enalapril—Perindopril—ABCB1—kidney cancer	0.000345	0.1	CrCbGaD
Enalapril—Nateglinide—PTGS1—kidney cancer	0.000313	0.091	CrCbGaD
Enalapril—Lisinopril—ABCB1—kidney cancer	0.000304	0.0882	CrCbGaD
Enalapril—Cilazapril—ABCB1—kidney cancer	0.000304	0.0882	CrCbGaD
Enalapril—Palpitations—Paclitaxel—kidney cancer	0.000121	0.000468	CcSEcCtD
Enalapril—Hyponatraemia—Doxorubicin—kidney cancer	0.000121	0.000467	CcSEcCtD
Enalapril—Insomnia—Gemcitabine—kidney cancer	0.000121	0.000467	CcSEcCtD
Enalapril—Headache—Erlotinib—kidney cancer	0.000121	0.000465	CcSEcCtD
Enalapril—Tinnitus—Capecitabine—kidney cancer	0.00012	0.000465	CcSEcCtD
Enalapril—Loss of consciousness—Paclitaxel—kidney cancer	0.00012	0.000465	CcSEcCtD
Enalapril—Constipation—Vincristine—kidney cancer	0.00012	0.000465	CcSEcCtD
Enalapril—Pain in extremity—Doxorubicin—kidney cancer	0.00012	0.000465	CcSEcCtD
Enalapril—Paraesthesia—Gemcitabine—kidney cancer	0.00012	0.000463	CcSEcCtD
Enalapril—Flushing—Capecitabine—kidney cancer	0.00012	0.000463	CcSEcCtD
Enalapril—Cough—Paclitaxel—kidney cancer	0.00012	0.000462	CcSEcCtD
Enalapril—Asthenia—Sunitinib—kidney cancer	0.000119	0.000461	CcSEcCtD
Enalapril—Dyspnoea—Gemcitabine—kidney cancer	0.000119	0.00046	CcSEcCtD
Enalapril—Nausea—Vinblastine—kidney cancer	0.000119	0.000459	CcSEcCtD
Enalapril—Somnolence—Gemcitabine—kidney cancer	0.000119	0.000459	CcSEcCtD
Enalapril—Nausea—Everolimus—kidney cancer	0.000118	0.000457	CcSEcCtD
Enalapril—Diarrhoea—Sorafenib—kidney cancer	0.000118	0.000457	CcSEcCtD
Enalapril—Pruritus—Sunitinib—kidney cancer	0.000118	0.000455	CcSEcCtD
Enalapril—Myalgia—Paclitaxel—kidney cancer	0.000117	0.000451	CcSEcCtD
Enalapril—Chest pain—Paclitaxel—kidney cancer	0.000117	0.000451	CcSEcCtD
Enalapril—Arthralgia—Paclitaxel—kidney cancer	0.000117	0.000451	CcSEcCtD
Enalapril—Face oedema—Doxorubicin—kidney cancer	0.000116	0.000449	CcSEcCtD
Enalapril—Decreased appetite—Gemcitabine—kidney cancer	0.000116	0.000449	CcSEcCtD
Enalapril—Hypersensitivity—Dactinomycin—kidney cancer	0.000116	0.000449	CcSEcCtD
Enalapril—Arrhythmia—Capecitabine—kidney cancer	0.000115	0.000446	CcSEcCtD
Enalapril—Discomfort—Paclitaxel—kidney cancer	0.000115	0.000445	CcSEcCtD
Enalapril—Fatigue—Gemcitabine—kidney cancer	0.000115	0.000445	CcSEcCtD
Enalapril—Gastrointestinal pain—Vincristine—kidney cancer	0.000115	0.000445	CcSEcCtD
Enalapril—Cardiac arrest—Doxorubicin—kidney cancer	0.000114	0.000442	CcSEcCtD
Enalapril—Dizziness—Sorafenib—kidney cancer	0.000114	0.000442	CcSEcCtD
Enalapril—Constipation—Gemcitabine—kidney cancer	0.000114	0.000441	CcSEcCtD
Enalapril—Nausea—Erlotinib—kidney cancer	0.000114	0.000441	CcSEcCtD
Enalapril—Alopecia—Capecitabine—kidney cancer	0.000114	0.000441	CcSEcCtD
Enalapril—Dry mouth—Paclitaxel—kidney cancer	0.000114	0.000441	CcSEcCtD
Enalapril—Diarrhoea—Sunitinib—kidney cancer	0.000114	0.00044	CcSEcCtD
Enalapril—Ataxia—Doxorubicin—kidney cancer	0.000113	0.000437	CcSEcCtD
Enalapril—Asthenia—Dactinomycin—kidney cancer	0.000113	0.000437	CcSEcCtD
Enalapril—Confusional state—Paclitaxel—kidney cancer	0.000113	0.000436	CcSEcCtD
Enalapril—Blood creatinine increased—Doxorubicin—kidney cancer	0.000113	0.000436	CcSEcCtD
Enalapril—Erythema—Capecitabine—kidney cancer	0.000112	0.000435	CcSEcCtD
Enalapril—Oedema—Paclitaxel—kidney cancer	0.000112	0.000432	CcSEcCtD
Enalapril—Anaphylactic shock—Paclitaxel—kidney cancer	0.000112	0.000432	CcSEcCtD
Enalapril—Abdominal pain—Vincristine—kidney cancer	0.000111	0.00043	CcSEcCtD
Enalapril—Body temperature increased—Vincristine—kidney cancer	0.000111	0.00043	CcSEcCtD
Enalapril—Flatulence—Capecitabine—kidney cancer	0.000111	0.000428	CcSEcCtD
Enalapril—Dry skin—Doxorubicin—kidney cancer	0.00011	0.000426	CcSEcCtD
Enalapril—Dysgeusia—Capecitabine—kidney cancer	0.00011	0.000425	CcSEcCtD
Enalapril—Dizziness—Sunitinib—kidney cancer	0.00011	0.000425	CcSEcCtD
Enalapril—Feeling abnormal—Gemcitabine—kidney cancer	0.00011	0.000425	CcSEcCtD
Enalapril—Shock—Paclitaxel—kidney cancer	0.00011	0.000425	CcSEcCtD
Enalapril—Vomiting—Sorafenib—kidney cancer	0.00011	0.000425	CcSEcCtD
Enalapril—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00011	0.000425	CcSEcCtD
Enalapril—Thrombocytopenia—Paclitaxel—kidney cancer	0.00011	0.000423	CcSEcCtD
Enalapril—Tachycardia—Paclitaxel—kidney cancer	0.000109	0.000422	CcSEcCtD
Enalapril—Rash—Sorafenib—kidney cancer	0.000109	0.000421	CcSEcCtD
Enalapril—Dermatitis—Sorafenib—kidney cancer	0.000109	0.000421	CcSEcCtD
Enalapril—Back pain—Capecitabine—kidney cancer	0.000109	0.00042	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000108	0.000419	CcSEcCtD
Enalapril—Headache—Sorafenib—kidney cancer	0.000108	0.000419	CcSEcCtD
Enalapril—Muscle spasms—Capecitabine—kidney cancer	0.000108	0.000418	CcSEcCtD
Enalapril—Hyperhidrosis—Paclitaxel—kidney cancer	0.000108	0.000418	CcSEcCtD
Enalapril—Diarrhoea—Dactinomycin—kidney cancer	0.000108	0.000417	CcSEcCtD
Enalapril—Nasopharyngitis—Doxorubicin—kidney cancer	0.000108	0.000416	CcSEcCtD
Enalapril—Anorexia—Paclitaxel—kidney cancer	0.000107	0.000412	CcSEcCtD
Enalapril—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000106	0.00041	CcSEcCtD
Enalapril—Vision blurred—Capecitabine—kidney cancer	0.000106	0.000409	CcSEcCtD
Enalapril—Vomiting—Sunitinib—kidney cancer	0.000106	0.000409	CcSEcCtD
Enalapril—Body temperature increased—Gemcitabine—kidney cancer	0.000106	0.000408	CcSEcCtD
Enalapril—Tremor—Capecitabine—kidney cancer	0.000105	0.000407	CcSEcCtD
Enalapril—Rash—Sunitinib—kidney cancer	0.000105	0.000406	CcSEcCtD
Enalapril—Dermatitis—Sunitinib—kidney cancer	0.000105	0.000405	CcSEcCtD
Enalapril—Hypotension—Paclitaxel—kidney cancer	0.000105	0.000404	CcSEcCtD
Enalapril—Headache—Sunitinib—kidney cancer	0.000104	0.000403	CcSEcCtD
Enalapril—Asthma—Doxorubicin—kidney cancer	0.000104	0.000402	CcSEcCtD
Enalapril—Dysphagia—Doxorubicin—kidney cancer	0.000104	0.000402	CcSEcCtD
Enalapril—Influenza—Doxorubicin—kidney cancer	0.000104	0.000402	CcSEcCtD
Enalapril—Anaemia—Capecitabine—kidney cancer	0.000104	0.000402	CcSEcCtD
Enalapril—Hypersensitivity—Vincristine—kidney cancer	0.000104	0.000401	CcSEcCtD
Enalapril—Eosinophilia—Doxorubicin—kidney cancer	0.000103	0.000398	CcSEcCtD
Enalapril—Nausea—Sorafenib—kidney cancer	0.000103	0.000397	CcSEcCtD
Enalapril—Pancreatitis—Doxorubicin—kidney cancer	0.000102	0.000394	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000102	0.000394	CcSEcCtD
Enalapril—Angina pectoris—Doxorubicin—kidney cancer	0.000101	0.000392	CcSEcCtD
Enalapril—Insomnia—Paclitaxel—kidney cancer	0.000101	0.000391	CcSEcCtD
Enalapril—Vertigo—Capecitabine—kidney cancer	0.000101	0.00039	CcSEcCtD
Enalapril—Asthenia—Vincristine—kidney cancer	0.000101	0.00039	CcSEcCtD
Enalapril—Syncope—Capecitabine—kidney cancer	0.000101	0.00039	CcSEcCtD
Enalapril—Leukopenia—Capecitabine—kidney cancer	0.000101	0.000389	CcSEcCtD
Enalapril—Paraesthesia—Paclitaxel—kidney cancer	0.0001	0.000388	CcSEcCtD
Enalapril—Vomiting—Dactinomycin—kidney cancer	0.0001	0.000387	CcSEcCtD
Enalapril—Bronchitis—Doxorubicin—kidney cancer	0.0001	0.000387	CcSEcCtD
Enalapril—Dyspnoea—Paclitaxel—kidney cancer	9.97e-05	0.000385	CcSEcCtD
Enalapril—Somnolence—Paclitaxel—kidney cancer	9.95e-05	0.000384	CcSEcCtD
Enalapril—Palpitations—Capecitabine—kidney cancer	9.94e-05	0.000384	CcSEcCtD
Enalapril—Rash—Dactinomycin—kidney cancer	9.94e-05	0.000384	CcSEcCtD
Enalapril—Nausea—Sunitinib—kidney cancer	9.89e-05	0.000382	CcSEcCtD
Enalapril—Loss of consciousness—Capecitabine—kidney cancer	9.89e-05	0.000382	CcSEcCtD
Enalapril—Pancytopenia—Doxorubicin—kidney cancer	9.88e-05	0.000382	CcSEcCtD
Enalapril—Dyspepsia—Paclitaxel—kidney cancer	9.85e-05	0.00038	CcSEcCtD
Enalapril—Cough—Capecitabine—kidney cancer	9.82e-05	0.000379	CcSEcCtD
Enalapril—Dysuria—Doxorubicin—kidney cancer	9.73e-05	0.000376	CcSEcCtD
Enalapril—Neutropenia—Doxorubicin—kidney cancer	9.73e-05	0.000376	CcSEcCtD
Enalapril—Decreased appetite—Paclitaxel—kidney cancer	9.72e-05	0.000376	CcSEcCtD
Enalapril—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.67e-05	0.000374	CcSEcCtD
Enalapril—Fatigue—Paclitaxel—kidney cancer	9.64e-05	0.000373	CcSEcCtD
Enalapril—Diarrhoea—Vincristine—kidney cancer	9.64e-05	0.000372	CcSEcCtD
Enalapril—Pollakiuria—Doxorubicin—kidney cancer	9.61e-05	0.000371	CcSEcCtD
Enalapril—Asthenia—Gemcitabine—kidney cancer	9.59e-05	0.00037	CcSEcCtD
Enalapril—Arthralgia—Capecitabine—kidney cancer	9.58e-05	0.00037	CcSEcCtD
Enalapril—Myalgia—Capecitabine—kidney cancer	9.58e-05	0.00037	CcSEcCtD
Enalapril—Chest pain—Capecitabine—kidney cancer	9.58e-05	0.00037	CcSEcCtD
Enalapril—Constipation—Paclitaxel—kidney cancer	9.57e-05	0.00037	CcSEcCtD
Enalapril—Photosensitivity reaction—Doxorubicin—kidney cancer	9.5e-05	0.000367	CcSEcCtD
Enalapril—Discomfort—Capecitabine—kidney cancer	9.46e-05	0.000365	CcSEcCtD
Enalapril—Pruritus—Gemcitabine—kidney cancer	9.45e-05	0.000365	CcSEcCtD
Enalapril—Hyperglycaemia—Doxorubicin—kidney cancer	9.39e-05	0.000363	CcSEcCtD
Enalapril—Dry mouth—Capecitabine—kidney cancer	9.37e-05	0.000362	CcSEcCtD
Enalapril—Nausea—Dactinomycin—kidney cancer	9.36e-05	0.000362	CcSEcCtD
Enalapril—Pneumonia—Doxorubicin—kidney cancer	9.33e-05	0.00036	CcSEcCtD
Enalapril—Dizziness—Vincristine—kidney cancer	9.31e-05	0.00036	CcSEcCtD
Enalapril—Confusional state—Capecitabine—kidney cancer	9.26e-05	0.000358	CcSEcCtD
Enalapril—Feeling abnormal—Paclitaxel—kidney cancer	9.22e-05	0.000356	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	9.2e-05	0.000355	CcSEcCtD
Enalapril—Oedema—Capecitabine—kidney cancer	9.18e-05	0.000355	CcSEcCtD
Enalapril—Gastrointestinal pain—Paclitaxel—kidney cancer	9.15e-05	0.000353	CcSEcCtD
Enalapril—Diarrhoea—Gemcitabine—kidney cancer	9.14e-05	0.000353	CcSEcCtD
Enalapril—Renal failure—Doxorubicin—kidney cancer	9.12e-05	0.000352	CcSEcCtD
Enalapril—Neuropathy peripheral—Doxorubicin—kidney cancer	9.1e-05	0.000351	CcSEcCtD
Enalapril—Jaundice—Doxorubicin—kidney cancer	9.04e-05	0.000349	CcSEcCtD
Enalapril—Stomatitis—Doxorubicin—kidney cancer	9.04e-05	0.000349	CcSEcCtD
Enalapril—Shock—Capecitabine—kidney cancer	9.03e-05	0.000349	CcSEcCtD
Enalapril—Conjunctivitis—Doxorubicin—kidney cancer	9.02e-05	0.000348	CcSEcCtD
Enalapril—Urinary tract infection—Doxorubicin—kidney cancer	9.02e-05	0.000348	CcSEcCtD
Enalapril—Thrombocytopenia—Capecitabine—kidney cancer	8.99e-05	0.000347	CcSEcCtD
Enalapril—Tachycardia—Capecitabine—kidney cancer	8.96e-05	0.000346	CcSEcCtD
Enalapril—Vomiting—Vincristine—kidney cancer	8.96e-05	0.000346	CcSEcCtD
Enalapril—Urticaria—Paclitaxel—kidney cancer	8.89e-05	0.000343	CcSEcCtD
Enalapril—Rash—Vincristine—kidney cancer	8.88e-05	0.000343	CcSEcCtD
Enalapril—Hyperhidrosis—Capecitabine—kidney cancer	8.87e-05	0.000343	CcSEcCtD
Enalapril—Dermatitis—Vincristine—kidney cancer	8.87e-05	0.000343	CcSEcCtD
Enalapril—Abdominal pain—Paclitaxel—kidney cancer	8.84e-05	0.000342	CcSEcCtD
Enalapril—Body temperature increased—Paclitaxel—kidney cancer	8.84e-05	0.000342	CcSEcCtD
Enalapril—Headache—Vincristine—kidney cancer	8.82e-05	0.000341	CcSEcCtD
Enalapril—Epistaxis—Doxorubicin—kidney cancer	8.75e-05	0.000338	CcSEcCtD
Enalapril—Anorexia—Capecitabine—kidney cancer	8.75e-05	0.000338	CcSEcCtD
Enalapril—Sinusitis—Doxorubicin—kidney cancer	8.7e-05	0.000336	CcSEcCtD
Enalapril—Agranulocytosis—Doxorubicin—kidney cancer	8.66e-05	0.000334	CcSEcCtD
Enalapril—Hypotension—Capecitabine—kidney cancer	8.58e-05	0.000331	CcSEcCtD
Enalapril—Vomiting—Gemcitabine—kidney cancer	8.5e-05	0.000328	CcSEcCtD
Enalapril—Bradycardia—Doxorubicin—kidney cancer	8.48e-05	0.000328	CcSEcCtD
Enalapril—Rash—Gemcitabine—kidney cancer	8.42e-05	0.000325	CcSEcCtD
Enalapril—Dermatitis—Gemcitabine—kidney cancer	8.42e-05	0.000325	CcSEcCtD
Enalapril—Headache—Gemcitabine—kidney cancer	8.37e-05	0.000323	CcSEcCtD
Enalapril—Nausea—Vincristine—kidney cancer	8.37e-05	0.000323	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.36e-05	0.000323	CcSEcCtD
Enalapril—Hepatitis—Doxorubicin—kidney cancer	8.33e-05	0.000322	CcSEcCtD
Enalapril—Insomnia—Capecitabine—kidney cancer	8.3e-05	0.000321	CcSEcCtD
Enalapril—Pharyngitis—Doxorubicin—kidney cancer	8.27e-05	0.000319	CcSEcCtD
Enalapril—Paraesthesia—Capecitabine—kidney cancer	8.24e-05	0.000318	CcSEcCtD
Enalapril—Hypersensitivity—Paclitaxel—kidney cancer	8.24e-05	0.000318	CcSEcCtD
Enalapril—Dyspnoea—Capecitabine—kidney cancer	8.18e-05	0.000316	CcSEcCtD
Enalapril—Dyspepsia—Capecitabine—kidney cancer	8.08e-05	0.000312	CcSEcCtD
Enalapril—Visual impairment—Doxorubicin—kidney cancer	8.03e-05	0.00031	CcSEcCtD
Enalapril—Asthenia—Paclitaxel—kidney cancer	8.03e-05	0.00031	CcSEcCtD
Enalapril—Decreased appetite—Capecitabine—kidney cancer	7.98e-05	0.000308	CcSEcCtD
Enalapril—Nausea—Gemcitabine—kidney cancer	7.94e-05	0.000307	CcSEcCtD
Enalapril—Fatigue—Capecitabine—kidney cancer	7.91e-05	0.000306	CcSEcCtD
Enalapril—Pruritus—Paclitaxel—kidney cancer	7.91e-05	0.000306	CcSEcCtD
Enalapril—Erythema multiforme—Doxorubicin—kidney cancer	7.88e-05	0.000304	CcSEcCtD
Enalapril—Constipation—Capecitabine—kidney cancer	7.85e-05	0.000303	CcSEcCtD
Enalapril—Tinnitus—Doxorubicin—kidney cancer	7.77e-05	0.0003	CcSEcCtD
Enalapril—Flushing—Doxorubicin—kidney cancer	7.73e-05	0.000299	CcSEcCtD
Enalapril—Diarrhoea—Paclitaxel—kidney cancer	7.65e-05	0.000296	CcSEcCtD
Enalapril—Feeling abnormal—Capecitabine—kidney cancer	7.57e-05	0.000292	CcSEcCtD
Enalapril—Gastrointestinal pain—Capecitabine—kidney cancer	7.51e-05	0.00029	CcSEcCtD
Enalapril—Arrhythmia—Doxorubicin—kidney cancer	7.44e-05	0.000287	CcSEcCtD
Enalapril—Dizziness—Paclitaxel—kidney cancer	7.4e-05	0.000286	CcSEcCtD
Enalapril—Alopecia—Doxorubicin—kidney cancer	7.36e-05	0.000284	CcSEcCtD
Enalapril—Urticaria—Capecitabine—kidney cancer	7.29e-05	0.000282	CcSEcCtD
Enalapril—Body temperature increased—Capecitabine—kidney cancer	7.26e-05	0.00028	CcSEcCtD
Enalapril—Abdominal pain—Capecitabine—kidney cancer	7.26e-05	0.00028	CcSEcCtD
Enalapril—Erythema—Doxorubicin—kidney cancer	7.25e-05	0.00028	CcSEcCtD
Enalapril—Flatulence—Doxorubicin—kidney cancer	7.14e-05	0.000276	CcSEcCtD
Enalapril—Tension—Doxorubicin—kidney cancer	7.12e-05	0.000275	CcSEcCtD
Enalapril—Vomiting—Paclitaxel—kidney cancer	7.11e-05	0.000275	CcSEcCtD
Enalapril—Dysgeusia—Doxorubicin—kidney cancer	7.1e-05	0.000274	CcSEcCtD
Enalapril—Rash—Paclitaxel—kidney cancer	7.05e-05	0.000272	CcSEcCtD
Enalapril—Dermatitis—Paclitaxel—kidney cancer	7.05e-05	0.000272	CcSEcCtD
Enalapril—Nervousness—Doxorubicin—kidney cancer	7.04e-05	0.000272	CcSEcCtD
Enalapril—Back pain—Doxorubicin—kidney cancer	7.01e-05	0.000271	CcSEcCtD
Enalapril—Headache—Paclitaxel—kidney cancer	7.01e-05	0.000271	CcSEcCtD
Enalapril—Muscle spasms—Doxorubicin—kidney cancer	6.97e-05	0.000269	CcSEcCtD
Enalapril—Vision blurred—Doxorubicin—kidney cancer	6.83e-05	0.000264	CcSEcCtD
Enalapril—Hypersensitivity—Capecitabine—kidney cancer	6.76e-05	0.000261	CcSEcCtD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	6.73e-05	0.00638	CbGpPWpGaD
Enalapril—Anaemia—Doxorubicin—kidney cancer	6.7e-05	0.000259	CcSEcCtD
Enalapril—Agitation—Doxorubicin—kidney cancer	6.66e-05	0.000257	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—ST3GAL2—kidney cancer	6.65e-05	0.0063	CbGpPWpGaD
Enalapril—Nausea—Paclitaxel—kidney cancer	6.64e-05	0.000257	CcSEcCtD
Enalapril—Asthenia—Capecitabine—kidney cancer	6.59e-05	0.000254	CcSEcCtD
Enalapril—Vertigo—Doxorubicin—kidney cancer	6.51e-05	0.000252	CcSEcCtD
Enalapril—Syncope—Doxorubicin—kidney cancer	6.5e-05	0.000251	CcSEcCtD
Enalapril—ACE—Peptide hormone metabolism—CTNNB1—kidney cancer	6.5e-05	0.00616	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—EEF2—kidney cancer	6.5e-05	0.00616	CbGpPWpGaD
Enalapril—Pruritus—Capecitabine—kidney cancer	6.5e-05	0.000251	CcSEcCtD
Enalapril—Leukopenia—Doxorubicin—kidney cancer	6.49e-05	0.000251	CcSEcCtD
Enalapril—Palpitations—Doxorubicin—kidney cancer	6.41e-05	0.000248	CcSEcCtD
Enalapril—Loss of consciousness—Doxorubicin—kidney cancer	6.37e-05	0.000246	CcSEcCtD
Enalapril—Cough—Doxorubicin—kidney cancer	6.33e-05	0.000244	CcSEcCtD
Enalapril—Diarrhoea—Capecitabine—kidney cancer	6.28e-05	0.000243	CcSEcCtD
Enalapril—Myalgia—Doxorubicin—kidney cancer	6.17e-05	0.000238	CcSEcCtD
Enalapril—Chest pain—Doxorubicin—kidney cancer	6.17e-05	0.000238	CcSEcCtD
Enalapril—Arthralgia—Doxorubicin—kidney cancer	6.17e-05	0.000238	CcSEcCtD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	6.17e-05	0.00585	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—RYR1—kidney cancer	6.15e-05	0.00583	CbGpPWpGaD
Enalapril—Discomfort—Doxorubicin—kidney cancer	6.1e-05	0.000236	CcSEcCtD
Enalapril—Dizziness—Capecitabine—kidney cancer	6.07e-05	0.000234	CcSEcCtD
Enalapril—Dry mouth—Doxorubicin—kidney cancer	6.04e-05	0.000233	CcSEcCtD
Enalapril—Confusional state—Doxorubicin—kidney cancer	5.97e-05	0.00023	CcSEcCtD
Enalapril—Anaphylactic shock—Doxorubicin—kidney cancer	5.92e-05	0.000229	CcSEcCtD
Enalapril—Oedema—Doxorubicin—kidney cancer	5.92e-05	0.000229	CcSEcCtD
Enalapril—Vomiting—Capecitabine—kidney cancer	5.84e-05	0.000225	CcSEcCtD
Enalapril—Shock—Doxorubicin—kidney cancer	5.82e-05	0.000225	CcSEcCtD
Enalapril—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	5.8e-05	0.0055	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	5.8e-05	0.0055	CbGpPWpGaD
Enalapril—Thrombocytopenia—Doxorubicin—kidney cancer	5.79e-05	0.000224	CcSEcCtD
Enalapril—Rash—Capecitabine—kidney cancer	5.79e-05	0.000224	CcSEcCtD
Enalapril—Dermatitis—Capecitabine—kidney cancer	5.78e-05	0.000223	CcSEcCtD
Enalapril—Tachycardia—Doxorubicin—kidney cancer	5.78e-05	0.000223	CcSEcCtD
Enalapril—Headache—Capecitabine—kidney cancer	5.75e-05	0.000222	CcSEcCtD
Enalapril—Hyperhidrosis—Doxorubicin—kidney cancer	5.72e-05	0.000221	CcSEcCtD
Enalapril—SLC22A7—Fluoropyrimidine Activity—TP53—kidney cancer	5.65e-05	0.00536	CbGpPWpGaD
Enalapril—Anorexia—Doxorubicin—kidney cancer	5.64e-05	0.000218	CcSEcCtD
Enalapril—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	5.61e-05	0.00531	CbGpPWpGaD
Enalapril—Hypotension—Doxorubicin—kidney cancer	5.53e-05	0.000214	CcSEcCtD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	5.48e-05	0.00519	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—RYR1—kidney cancer	5.46e-05	0.00518	CbGpPWpGaD
Enalapril—Nausea—Capecitabine—kidney cancer	5.45e-05	0.000211	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.39e-05	0.000208	CcSEcCtD
Enalapril—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	5.38e-05	0.0051	CbGpPWpGaD
Enalapril—Insomnia—Doxorubicin—kidney cancer	5.35e-05	0.000207	CcSEcCtD
Enalapril—Paraesthesia—Doxorubicin—kidney cancer	5.31e-05	0.000205	CcSEcCtD
Enalapril—Dyspnoea—Doxorubicin—kidney cancer	5.28e-05	0.000204	CcSEcCtD
Enalapril—Somnolence—Doxorubicin—kidney cancer	5.26e-05	0.000203	CcSEcCtD
Enalapril—Dyspepsia—Doxorubicin—kidney cancer	5.21e-05	0.000201	CcSEcCtD
Enalapril—Decreased appetite—Doxorubicin—kidney cancer	5.14e-05	0.000199	CcSEcCtD
Enalapril—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	5.13e-05	0.00487	CbGpPWpGaD
Enalapril—Fatigue—Doxorubicin—kidney cancer	5.1e-05	0.000197	CcSEcCtD
Enalapril—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	5.1e-05	0.00484	CbGpPWpGaD
Enalapril—Constipation—Doxorubicin—kidney cancer	5.06e-05	0.000195	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—MME—kidney cancer	4.98e-05	0.00472	CbGpPWpGaD
Enalapril—CYP3A4—Irinotecan Pathway—APC—kidney cancer	4.89e-05	0.00463	CbGpPWpGaD
Enalapril—Feeling abnormal—Doxorubicin—kidney cancer	4.88e-05	0.000188	CcSEcCtD
Enalapril—Gastrointestinal pain—Doxorubicin—kidney cancer	4.84e-05	0.000187	CcSEcCtD
Enalapril—Urticaria—Doxorubicin—kidney cancer	4.7e-05	0.000182	CcSEcCtD
Enalapril—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	4.69e-05	0.00445	CbGpPWpGaD
Enalapril—Body temperature increased—Doxorubicin—kidney cancer	4.68e-05	0.000181	CcSEcCtD
Enalapril—Abdominal pain—Doxorubicin—kidney cancer	4.68e-05	0.000181	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—RPL14—kidney cancer	4.63e-05	0.00439	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—HSPD1—kidney cancer	4.63e-05	0.00439	CbGpPWpGaD
Enalapril—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	4.51e-05	0.00428	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	4.45e-05	0.00422	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	4.36e-05	0.00414	CbGpPWpGaD
Enalapril—Hypersensitivity—Doxorubicin—kidney cancer	4.36e-05	0.000168	CcSEcCtD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.35e-05	0.00413	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—ACY1—kidney cancer	4.31e-05	0.00409	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL13—kidney cancer	4.28e-05	0.00405	CbGpPWpGaD
Enalapril—Asthenia—Doxorubicin—kidney cancer	4.25e-05	0.000164	CcSEcCtD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	4.21e-05	0.00399	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.2e-05	0.00398	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ANXA2—kidney cancer	4.2e-05	0.00398	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.2e-05	0.00398	CbGpPWpGaD
Enalapril—Pruritus—Doxorubicin—kidney cancer	4.19e-05	0.000162	CcSEcCtD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	4.12e-05	0.00391	CbGpPWpGaD
Enalapril—Diarrhoea—Doxorubicin—kidney cancer	4.05e-05	0.000156	CcSEcCtD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	4.03e-05	0.00382	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	3.98e-05	0.00377	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.97e-05	0.00377	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.97e-05	0.00377	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.97e-05	0.00377	CbGpPWpGaD
Enalapril—Dizziness—Doxorubicin—kidney cancer	3.91e-05	0.000151	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—ACHE—kidney cancer	3.82e-05	0.00362	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—EIF4EBP1—kidney cancer	3.78e-05	0.00358	CbGpPWpGaD
Enalapril—Vomiting—Doxorubicin—kidney cancer	3.76e-05	0.000145	CcSEcCtD
Enalapril—Rash—Doxorubicin—kidney cancer	3.73e-05	0.000144	CcSEcCtD
Enalapril—Dermatitis—Doxorubicin—kidney cancer	3.73e-05	0.000144	CcSEcCtD
Enalapril—Headache—Doxorubicin—kidney cancer	3.71e-05	0.000143	CcSEcCtD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	3.67e-05	0.00348	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—PAX6—kidney cancer	3.63e-05	0.00345	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CTSD—kidney cancer	3.62e-05	0.00343	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	3.54e-05	0.00336	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.53e-05	0.00335	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.53e-05	0.00335	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.53e-05	0.00335	CbGpPWpGaD
Enalapril—Nausea—Doxorubicin—kidney cancer	3.52e-05	0.000136	CcSEcCtD
Enalapril—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	3.5e-05	0.00332	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	3.33e-05	0.00316	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—BCHE—kidney cancer	3.33e-05	0.00315	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	3.26e-05	0.00309	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	3.14e-05	0.00298	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.14e-05	0.00297	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.14e-05	0.00297	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.14e-05	0.00297	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	3.06e-05	0.0029	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	2.96e-05	0.0028	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.95e-05	0.00279	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.95e-05	0.00279	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.95e-05	0.00279	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	2.91e-05	0.00276	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ACY1—kidney cancer	2.8e-05	0.00265	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	2.6e-05	0.00247	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—IGF2—kidney cancer	2.58e-05	0.00244	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	2.51e-05	0.00238	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	2.51e-05	0.00238	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	2.45e-05	0.00232	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	2.41e-05	0.00228	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.38e-05	0.00226	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	2.38e-05	0.00226	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PDHB—kidney cancer	2.38e-05	0.00225	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	2.36e-05	0.00224	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	2.34e-05	0.00222	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CCBL1—kidney cancer	2.24e-05	0.00212	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.22e-05	0.0021	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.14e-05	0.00203	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.09e-05	0.00199	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	2.09e-05	0.00198	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	2.07e-05	0.00197	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.02e-05	0.00192	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.02e-05	0.00192	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.95e-05	0.00185	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PPAT—kidney cancer	1.94e-05	0.00184	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GLIPR1—kidney cancer	1.94e-05	0.00184	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.92e-05	0.00182	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.91e-05	0.00181	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	1.9e-05	0.00181	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.89e-05	0.0018	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.86e-05	0.00177	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—FH—kidney cancer	1.8e-05	0.00171	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—APRT—kidney cancer	1.8e-05	0.00171	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.8e-05	0.00171	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.76e-05	0.00167	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—POMC—kidney cancer	1.72e-05	0.00163	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	1.71e-05	0.00162	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	1.71e-05	0.00162	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GPC3—kidney cancer	1.69e-05	0.00161	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.69e-05	0.0016	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.65e-05	0.00157	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CA2—kidney cancer	1.65e-05	0.00156	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALAD—kidney cancer	1.61e-05	0.00152	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	1.6e-05	0.00152	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	1.6e-05	0.00152	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.6e-05	0.00151	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.6e-05	0.00151	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.58e-05	0.0015	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.57e-05	0.00149	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ST3GAL2—kidney cancer	1.57e-05	0.00149	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.55e-05	0.00147	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALDH1A1—kidney cancer	1.53e-05	0.00145	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.5e-05	0.00142	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC5A3—kidney cancer	1.47e-05	0.00139	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PGK1—kidney cancer	1.47e-05	0.00139	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.45e-05	0.00138	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—LDHB—kidney cancer	1.44e-05	0.00137	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.42e-05	0.00135	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.4e-05	0.00133	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL2—kidney cancer	1.4e-05	0.00133	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.39e-05	0.00132	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.39e-05	0.00132	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.37e-05	0.0013	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.34e-05	0.00127	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.34e-05	0.00127	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.34e-05	0.00127	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.3e-05	0.00123	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.26e-05	0.0012	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CA9—kidney cancer	1.25e-05	0.00118	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CTNNB1—kidney cancer	1.23e-05	0.00116	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.22e-05	0.00116	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ACY1—kidney cancer	1.2e-05	0.00113	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.19e-05	0.00113	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.19e-05	0.00112	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.18e-05	0.00112	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CRABP1—kidney cancer	1.06e-05	0.00101	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PDHB—kidney cancer	1.02e-05	0.000965	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ITPR2—kidney cancer	9.87e-06	0.000936	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	9.8e-06	0.000929	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTP1—kidney cancer	9.63e-06	0.000913	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CCBL1—kidney cancer	9.57e-06	0.000907	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—RAF1—kidney cancer	9.56e-06	0.000907	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	9.49e-06	0.0009	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.1e-06	0.000863	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—RAF1—kidney cancer	9.04e-06	0.000857	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTT1—kidney cancer	9e-06	0.000854	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ACHE—kidney cancer	9e-06	0.000854	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTM1—kidney cancer	8.85e-06	0.000839	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	8.72e-06	0.000827	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SCARB1—kidney cancer	8.52e-06	0.000808	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTGS1—kidney cancer	8.44e-06	0.0008	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	8.39e-06	0.000795	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GLIPR1—kidney cancer	8.3e-06	0.000787	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PPAT—kidney cancer	8.3e-06	0.000787	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PSMD7—kidney cancer	8.27e-06	0.000784	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	8.27e-06	0.000784	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	8.04e-06	0.000762	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—BCHE—kidney cancer	7.84e-06	0.000744	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC5A5—kidney cancer	7.75e-06	0.000735	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—APRT—kidney cancer	7.71e-06	0.000731	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—FH—kidney cancer	7.71e-06	0.000731	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	7.69e-06	0.000729	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	7.61e-06	0.000722	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC2A1—kidney cancer	7.48e-06	0.000709	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	7.44e-06	0.000706	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ACY1—kidney cancer	7.38e-06	0.000699	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.26e-06	0.000688	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GPC3—kidney cancer	7.25e-06	0.000688	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—RAF1—kidney cancer	7.14e-06	0.000677	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.08e-06	0.000671	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CA2—kidney cancer	7.06e-06	0.000669	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	7.05e-06	0.000668	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALAD—kidney cancer	6.88e-06	0.000652	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.84e-06	0.000648	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	6.73e-06	0.000638	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ST3GAL2—kidney cancer	6.71e-06	0.000636	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	6.71e-06	0.000636	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	6.71e-06	0.000636	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	6.66e-06	0.000631	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALDH1A1—kidney cancer	6.56e-06	0.000622	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	6.49e-06	0.000615	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.33e-06	0.0006	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PGK1—kidney cancer	6.29e-06	0.000596	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC5A3—kidney cancer	6.29e-06	0.000596	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PDHB—kidney cancer	6.27e-06	0.000595	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—POMC—kidney cancer	6.25e-06	0.000593	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTP1—kidney cancer	6.24e-06	0.000592	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—LDHB—kidney cancer	6.17e-06	0.000585	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ABCB1—kidney cancer	5.91e-06	0.00056	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CCBL1—kidney cancer	5.9e-06	0.000559	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.86e-06	0.000556	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTM1—kidney cancer	5.74e-06	0.000544	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.55e-06	0.000526	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP1A1—kidney cancer	5.44e-06	0.000515	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.39e-06	0.000511	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CA9—kidney cancer	5.35e-06	0.000507	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.28e-06	0.0005	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GLIPR1—kidney cancer	5.11e-06	0.000485	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PPAT—kidney cancer	5.11e-06	0.000485	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.98e-06	0.000473	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—FH—kidney cancer	4.75e-06	0.000451	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—APRT—kidney cancer	4.75e-06	0.000451	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.58e-06	0.000434	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CRABP1—kidney cancer	4.55e-06	0.000431	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GPC3—kidney cancer	4.47e-06	0.000424	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.47e-06	0.000423	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.43e-06	0.00042	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CA2—kidney cancer	4.35e-06	0.000412	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALAD—kidney cancer	4.24e-06	0.000402	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ITPR2—kidney cancer	4.23e-06	0.000401	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.13e-06	0.000392	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—POMC—kidney cancer	4.05e-06	0.000384	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.04e-06	0.000383	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.87e-06	0.000367	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PGK1—kidney cancer	3.87e-06	0.000367	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTT1—kidney cancer	3.85e-06	0.000365	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ACHE—kidney cancer	3.85e-06	0.000365	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—LDHB—kidney cancer	3.8e-06	0.00036	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SCARB1—kidney cancer	3.65e-06	0.000346	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTGS1—kidney cancer	3.61e-06	0.000342	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PSMD7—kidney cancer	3.54e-06	0.000336	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—BCHE—kidney cancer	3.36e-06	0.000318	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC5A5—kidney cancer	3.32e-06	0.000314	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CA9—kidney cancer	3.29e-06	0.000312	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTGS2—kidney cancer	3.23e-06	0.000307	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC2A1—kidney cancer	3.2e-06	0.000304	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.05e-06	0.00029	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTEN—kidney cancer	2.82e-06	0.000267	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CRABP1—kidney cancer	2.8e-06	0.000266	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTP1—kidney cancer	2.67e-06	0.000253	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ITPR2—kidney cancer	2.6e-06	0.000247	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTM1—kidney cancer	2.46e-06	0.000233	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ACHE—kidney cancer	2.37e-06	0.000225	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTT1—kidney cancer	2.37e-06	0.000225	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP1A1—kidney cancer	2.33e-06	0.000221	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SCARB1—kidney cancer	2.25e-06	0.000213	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTGS1—kidney cancer	2.23e-06	0.000211	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PSMD7—kidney cancer	2.18e-06	0.000207	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—BCHE—kidney cancer	2.07e-06	0.000196	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.04e-06	0.000194	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CA—kidney cancer	1.99e-06	0.000189	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.97e-06	0.000187	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—POMC—kidney cancer	1.74e-06	0.000165	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTP1—kidney cancer	1.65e-06	0.000156	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ABCB1—kidney cancer	1.56e-06	0.000148	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTM1—kidney cancer	1.51e-06	0.000143	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.43e-06	0.000136	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTGS2—kidney cancer	1.38e-06	0.000131	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTEN—kidney cancer	1.21e-06	0.000114	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—POMC—kidney cancer	1.07e-06	0.000101	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTGS2—kidney cancer	8.53e-07	8.09e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CA—kidney cancer	8.52e-07	8.07e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTEN—kidney cancer	7.44e-07	7.05e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.25e-07	4.97e-05	CbGpPWpGaD
